Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IC14 for ALS Patients Expanded Access

NCT04309604 is registered in ClinicalTrials.gov with Implicit Bioscience as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04309604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IC14 for ALS Patients Expanded Access
Lead sponsor
Implicit Bioscience
Phase
Expanded access
Overall status
No longer available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.